These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 2188893

  • 1. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
    Antoni H, Weirich J.
    Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
    [Abstract] [Full Text] [Related]

  • 2. [New aspects of the molecular effect of anti-arrhythmia agents].
    Honerjäger P.
    Herz; 1990 Apr; 15(2):70-8. PubMed ID: 2160907
    [Abstract] [Full Text] [Related]

  • 3. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].
    Steinbeck G.
    Z Kardiol; 1992 Apr; 81 Suppl 4():139-43. PubMed ID: 1290290
    [Abstract] [Full Text] [Related]

  • 4. [Principles for the classification of anti-arrhythmia agents in cardiac arrhythmias].
    Ravens U.
    Z Kardiol; 1992 Apr; 81 Suppl 4():119-25. PubMed ID: 1290288
    [Abstract] [Full Text] [Related]

  • 5. The relevance of cellular to clinical electrophysiology in classifying antiarrhythmic actions.
    Vaughan Williams EM.
    J Cardiovasc Pharmacol; 1992 Apr; 20 Suppl 2():S1-7. PubMed ID: 1279301
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Voltage- and rate-dependent depression of Vmax of action potentials by a new antiarrhythmic agent, E-0747, in swine cardiac Purkinje fibers.
    Sawada K, Shoji T, Igarashi T, Hiraoka M.
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):51-6. PubMed ID: 2434794
    [Abstract] [Full Text] [Related]

  • 14. [Antiarrhythmic agents. Receptor hypothesis explains mechanisms of action].
    Bjørnstad H, Refsum H.
    Tidsskr Nor Laegeforen; 1991 Oct 30; 111(26):3187-9. PubMed ID: 1658976
    [Abstract] [Full Text] [Related]

  • 15. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms.
    Masotti CS, Pierangeli A.
    Panminerva Med; 1999 Dec 30; 41(4):295-306. PubMed ID: 10705709
    [Abstract] [Full Text] [Related]

  • 16. Open and inactivated sodium channel block by class-I antiarrhythmic drugs.
    Kodama I, Toyama J, Yamada K.
    Jpn Heart J; 1986 Nov 30; 27 Suppl 1():83-9. PubMed ID: 2434686
    [Abstract] [Full Text] [Related]

  • 17. Frequency and voltage-dependent effects of mono-N-dealkyldisopyramide, the major metabolite of disopyramide, in canine ventricular tissue.
    Toy W, Sasyniuk BI.
    J Pharmacol Exp Ther; 1990 Aug 30; 254(2):603-11. PubMed ID: 2166798
    [Abstract] [Full Text] [Related]

  • 18. Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview.
    Dorian P, Newman D.
    Europace; 2000 Oct 30; 2(4):277-85. PubMed ID: 11194593
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Anti-arrhythmic and cardiodepressive effects of anti-arrhythmia agents].
    Scholz H.
    Z Kardiol; 1988 Oct 30; 77 Suppl 5():113-9. PubMed ID: 2464875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.